Viral Vector Manufacturing Market in terms of revenue was estimated to be worth $5.5 billion in 2023 and is poised to reach $12.8 billion by 2028, growing at a CAGR of 18.2% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth …
Introduction:The viral vector manufacturing market is witnessing remarkable growth due to the increasing demand for gene therapy and vaccine development. According to a recent report by MarketsandMarkets, The global viral vector manufacturing market is projected to reach USD 12.8 billion by 2028 from USD 5.5 …
According to a new market research report “Viral Vector Manufacturing Market by Type (Retrovirus, Gammaretrovirus, AAV), Disease (Cancer, Infectious Disease, Genetic Disorders), Application (Gene Therapy, Vaccinology), End User (Biotech companies, Research Institutes) – Global Forecast to 2023“, published by MarketsandMarkets™, the market is expected to reach USD 815.8 …
The global viral vector manufacturing market is projected to reach USD 12.8 billion by 2028 from USD 5.5 billion in 2023, at a CAGR of 18.2%. This market is consolidated in nature with a few global players. In 2017, Lonza (Switzerland), Merck (Germany), and Oxford …